Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

C-reactive protein, fibrin D-dimer, and incident ischemic heart disease in the Speedwell study: are inflammation and fibrin turnover linked in pathogenesis?

Lowe GD, Yarnell JW, Rumley A, Bainton D, Sweetnam PM.

Arterioscler Thromb Vasc Biol. 2001 Apr;21(4):603-10.

2.

C-reactive protein and primary prevention of ischemic heart disease.

Liuzzo G, Rizzello V.

Clin Chim Acta. 2001 Sep 15;311(1):45-8. Review.

PMID:
11557252
3.

Fibrin D-dimer in thrombogenic disorders.

Matsuo T, Kobayashi H, Kario K, Suzuki S.

Semin Thromb Hemost. 2000;26(1):101-7. Review.

PMID:
10805290
4.

[Ischemic cardiopathy: inflammation markers and the cardiovascular risk].

GarcĂ­a-Moll X, Carlos Kaski J.

Rev Esp Cardiol. 1999 Nov;52(11):990-1003. Review. Spanish.

5.

Haemostatic function and arterial disease.

Meade TW.

Br Med Bull. 1994 Oct;50(4):755-75. Review.

PMID:
7804729
6.

Fibrinogen in ischaemic heart disease.

Meade TW.

Eur Heart J. 1995 Mar;16 Suppl A:31-4; discussion 34-5. Review.

PMID:
7796828
7.

[Possible association between serum C-reactive protein concentrations and ischemic heart disease].

Shapira I, Zeltzer D, Berliner S.

Harefuah. 1999 Aug;137(3-4):149-53. Review. Hebrew. No abstract available.

PMID:
10959309
8.

Fibrin D-dimer: a useful clinical marker of thrombogenesis?

Lip GY, Lowe GD.

Clin Sci (Lond). 1995 Sep;89(3):205-14. Review. No abstract available.

PMID:
7493413
9.

D-dimer as a marker for cardiovascular and arterial thrombotic events in patients with peripheral arterial disease. A systematic review.

Kleinegris MC, ten Cate H, ten Cate-Hoek AJ.

Thromb Haemost. 2013 Aug;110(2):233-43. doi: 10.1160/TH13-01-0032. Epub 2013 Jun 20. Review.

PMID:
23784703
10.

[Biological and clinical significance of acute phase proteins with particular emphasis on the role of C-reactive protein].

Szczepanek D, Czochra M, Zderkiewicz E, Mosiewicz A, Harasimiuk A.

Wiad Lek. 1997;50(4-6):112-6. Review. Polish.

PMID:
9381712
11.

Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events.

Lowe GD, Rumley A.

Thromb Haemost. 1999 Aug;82(2):667-72. Review. No abstract available.

PMID:
10605766
12.

Magnesium in drinking water and ischemic heart disease.

Marx A, Neutra RR.

Epidemiol Rev. 1997;19(2):258-72. Review.

PMID:
9494787
13.

Potential clinical applications of C-reactive protein.

Okamura JM, Miyagi JM, Terada K, Hokama Y.

J Clin Lab Anal. 1990;4(3):231-5. Review.

PMID:
2112596
14.
15.

Gene-environment interaction in the determination of levels of plasma fibrinogen.

Humphries SE, Luong LA, Montgomery HE, Day IN, Mohamed-Ali V, Yudkin JS.

Thromb Haemost. 1999 Aug;82(2):818-25. Review. No abstract available.

PMID:
10605788
16.

Parameters associated with chronic spontaneous urticaria duration and severity: a systematic review.

Rabelo-Filardi R, Daltro-Oliveira R, Campos RA.

Int Arch Allergy Immunol. 2013;161(3):197-204. doi: 10.1159/000346896. Epub 2013 Mar 15. Review.

PMID:
23548885
17.

Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor?

Drouet L, Paolucci F, Pasqualini N, Laprade M, Ripoll L, Mazoyer E, Bal dit Sollier C, Vanhove N.

Blood Coagul Fibrinolysis. 1999 Feb;10 Suppl 1:S35-9. Review. No abstract available.

PMID:
10070816
18.

CRP is or is not a reliable marker of ischaemic heart disease?

Biasucci LM, Giubilato G, Graziani F, Piro M.

Lupus. 2005;14(9):752-5. Review.

PMID:
16218481
19.

[D dimer].

Kurokawa I, Kimura T, Kondo M, Araki K.

Nihon Rinsho. 1995 Mar;53 Su Pt 2:34-8. Review. Japanese. No abstract available.

PMID:
8753174
20.

State of the Art: Blood Biomarkers for Risk Stratification in Patients with Stable Ischemic Heart Disease.

Omland T, White HD.

Clin Chem. 2017 Jan;63(1):165-176. doi: 10.1373/clinchem.2016.255190. Epub 2016 Nov 4. Review.

PMID:
27815307

Supplemental Content

Support Center